(Q35678253)

9 August 2017

1 reference

title

Combining quinupristin/dalfopristin with other agents for resistant infections (English)

1 reference

9 August 2017

Jack Brown

1

0 references

author name string

Burgess B Freeman

series ordinal

2

1 reference

PubMed ID

14990776

9 August 2017

language of work or name

English

0 references

publication date

27 February 2004

1 reference

Annals of Pharmacotherapy

9 August 2017

1 reference

9 August 2017

38

1 reference

9 August 2017

4

1 reference

9 August 2017

677-685

1 reference

National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1990-May 1999, issued June 1999. A report from the NNIS System

9 August 2017

1 reference

Global epidemiology of antimicrobial resistance among community-acquired and nosocomial pathogens: a five-year summary from the SENTRY Antimicrobial Surveillance Program (1997-2001).

21 January 2018

1 reference

The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida

21 January 2018

1 reference

Therapeutic options for Gram-positive infections

21 January 2018

1 reference

Comparative in-vitro activity of RP 59500 against clinical bacterial isolates

21 January 2018

1 reference

High-level penicillin resistance among isolates of enterococci. Implications for treatment of enterococcal infections.

21 January 2018

1 reference

The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic options

21 January 2018

1 reference

Aminoglycoside resistance in enterococci

21 January 2018

1 reference

Regulation of VanA- and VanB-type glycopeptide resistance in enterococci

21 January 2018

1 reference

Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium.

21 January 2018

1 reference

Effects of ampicillin-amikacin and ampicillin-rifampin on enterococci

21 January 2018

1 reference

Antimicrobial activity of quinupristin-dalfopristin combined with other antibiotics against vancomycin-resistant enterococci

21 January 2018

1 reference

In vitro activities of quinupristin-dalfopristin and cefepime, alone and in combination with various antimicrobials, against multidrug-resistant staphylococci and enterococci in an in vitro pharmacodynamic model

21 January 2018

1 reference

Modified time-kill assay against multidrug-resistant Enterococcus faecium with novel antimicrobial combinations.

21 January 2018

1 reference

Treatment of endocarditis due to vancomycin-resistant Enterococcus faecium with quinupristin/dalfopristin, doxycycline, and rifampin: a synergistic drug combination

21 January 2018

1 reference

In vitro activity of chloramphenicol alone and in combination with vancomycin, ampicillin, or RP 59500 (quinupristin/dalfopristin) against vancomycin-resistant enterococci.

21 January 2018

1 reference

Bactericidal and inhibitory activity of quinupristin/dalfopristin against vancomycin- and gentamicin-resistant Enterococcus faecium

21 January 2018

1 reference

Antimicrobial resistance: the example of Staphylococcus aureus

21 January 2018

1 reference

Staphylococcus aureus infections

21 January 2018

1 reference

Susceptibility of gram-positive cocci from 25 UK hospitals to antimicrobial agents including linezolid. The Linezolid Study Group.

21 January 2018

1 reference

Antistaphylococcal (MSSA, MRSA, MSSE, MRSE) antibiotics

21 January 2018

1 reference

Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis

21 January 2018

1 reference

Inhibition of protein synthesis by streptogramins and related antibiotics

21 January 2018

1 reference

Antimicrobial susceptibility and molecular characterization of community-acquired methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

Suppression of beta-lactam antibiotic resistance in a methicillin- resistant Staphylococcus aureus through synergic action of early cell wall inhibitors and some other antibiotics

21 January 2018

1 reference

Quinupristin-dalfopristin combined with beta-lactams for treatment of experimental endocarditis due to Staphylococcus aureus constitutively resistant to macrolide-lincosamide-streptogramin B antibiotics

21 January 2018

1 reference

Interactions of quinupristin-dalfopristin with eight other antibiotics as measured by time-kill studies with 10 strains of Staphylococcus aureus for which quinupristin-dalfopristin alone was not bactericidal

21 January 2018

1 reference

In vitro activity of fosfomycin in combination with various antistaphylococcal substances.

21 January 2018

1 reference

Combination of quinupristin/dalfopristin and glycopeptide in severe methicillin-resistant staphylococcal infections failing previous glycopeptide regimens

21 January 2018

1 reference

Synercid plus vancomycin for the treatment of severe methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci infections: evaluation of 5 cases

21 January 2018

1 reference

Disseminated oxacillin-resistant Staphylococcus aureus infection responsive to vancomycin and quinupristin-dalfopristin combination therapy

21 January 2018

1 reference

In-vitro activity and killing effect of quinupristin/dalfopristin (RP59500) on nosocomial Staphylococcus aureus and interactions with rifampicin and ciprofloxacin against methicillin-resistant isolates

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1D323

1 reference

9 August 2017

1 reference

PubMed ID

14990776